Trial Profile
Effect of GLPIR Stimulation on Neuroprotection and Inflammation in Parkinson's Disease
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Semaglutide (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms GIPD
- 14 Sep 2018 New trial record